SLS
SELLAS LIFE SCIENCES GROUP IData as of 2026 Q2 (06-30) · 13F snapshot
Summary
SELLAS LIFE SCIENCES GROUP I (SLS) is held as common stock by 2 tracked hedge-fund managers, with a combined reported value of ~$5.68M; the largest are Renaissance Technologies, Joel Greenblatt. 3 tracked managers also disclosed PUT or CALL positions, reported separately below. This quarter: 2 new, 2 closed. Data as of 2026 Q2, from public SEC 13F filings, delayed up to ~45 days.
Attention · LowThis quarter · Mixed
Common-stock holders23 also report options
Congress trades0
Price$11.59vs quarter-end-21.48%
Sectors0
This quarter's moves
Top holderNew2
Added0
Trimmed / sold2
Renaissance TechnologiesCommon-stock positions
PUT and CALL disclosures are excluded from these holder counts and values.
| Investor | Value | % of portfolio | Action |
|---|
PUT / CALL disclosures
Reported separately: 13F option values are not common-stock ownership and do not reveal the full strategy or economic exposure.
Value $64.16M— of portfolio4,346,7002026 Q2
Value $33.33M— of portfolio2,258,4002026 Q2
Value $13.37M— of portfolio906,0002026 Q2
Value $3.09M— of portfolio209,2002026 Q2
Value $2.90M— of portfolio196,2002026 Q2
Value $2.07M— of portfolio140,2002026 Q2
| Investor | Value | % of portfolio | Action |
|---|---|---|---|
| Ken GriffinCALL | $64.16M | — | — |
| Ken GriffinPUT | $33.33M | — | — |
| Izzy EnglanderPUT | $13.37M | — | — |
| Paul Tudor JonesPUT | $3.09M | — | — |
| Izzy EnglanderCALL | $2.90M | — | — |
| Paul Tudor JonesCALL | $2.07M | — | — |
Public SEC 13F filings may appear up to 45 days after quarter-end; STOCK Act / OGE trade filings are generally due within 45 days but may be late. Partial data only — research, not investment advice.